Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine

Molecular Pharmacology

Volumn 52, Issue 4, 1997, Pages 571-581

  Pariante, Carmine M ^a,b   Pearce, Bradley D ^a   Pisell, Tracy L ^a   Owens, Michael J ^a   Miller, Andrew H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; CHLORAMPHENICOL ACETYLTRANSFERASE; DESIPRAMINE; DEXAMETHASONE; FIBRONECTIN; GLUCOCORTICOID RECEPTOR; RADIOLIGAND; STEROID; TRANSCRIPTION FACTOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN L 929; CONTROLLED STUDY; CYTOPLASM; DEPRESSION; DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRACELLULAR TRANSPORT; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE;

EID: 0030760364     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.4.571     Document Type: Article

References (40)

1. Owens, M. J., and C. B. Nemeroff. The role of CRF in the pathophysiology of affective disorders: laboratory and clinical studies, in Ciba Foundation Symposium on Corticotropin-Releasing Factor 172 (W. W. Vale, ed.). John Wiley & Sons, New York, 293-316 (1993).
2. Holsboer, F., and N. Barden. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:187-205 (1996).
3. Ribeiro, S. C. M., R. Tandon, L. Grunhaus, and J. F. Greden. The DST as a predictor of outcome in depression: a meta-analysis. Am. J. Psychiatry. 150:1618-1629 (1993).
4. Sapolsky, R. M., L. C. Krey, and B. S. McEwen. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7: 284-301 (1986).
5. Pariante, C. M., C. B. Nemeroff, and A. H. Miller. Glucocorticoid receptors in depression. Isr. J. Med. Sci. 31:705-712 (1995).
6. Miller, A. H., G. M. Asnis, C. Lackner, and A. J. Norin. The in vitro effect of cortisol on natural killer cell activity in patients with major depressive disorder. Psychopharmacol. Bull. 23:502-504 (1987).
7. Lowy, M. T., A. T. Reder, G. J. Gormley, and H. Y. Meltzer. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test. Biol. Psychiatry 24:619-630 (1988).
8. Wodarz, N., R. Rupprecht, J. Kornhuber, B. Schmitz, K. Wild, H. U. Braner, and P. Riederer. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression. J. Affect. Disord. 22:241-248 (1991).
9. Kitayama, I., A. M. Janson, A. Cintra, K. Fuxe, L. F. Agnati, S.-O. Ogren, A. Harfstrand, P. Eneroth, and J.-A. Gustafsson. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. J. Neural. Transm. 73:191-203 (1988).
10. Brady, L. S., H. J. Whitfield, Jr., R. J. Fox, P. W. Gold, and M. Herkenham. Long-term antidepressant administration alters corticotropin-releasing hormone tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J. Clin. Invest. 87: 831-837 (1991).
11. Peiffer, A., S. Veilleux, and N. Barden. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology 16:505-515 (1991).
12. Seckl, J. R., and G. Fink. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 55:621-626 (1992).
13. Reul, J. M. H. M., I. Stec, M. Soder, and F. Holsboer. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133:312-320 (1993).
14. Reul, J. M. H. M., M. S. Labeur, D. E. Grigoriadis, E. B. De Souza, and F. Holsboer. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60:509-519 (1994).
15. Przegalinski, E., B. Budziszewska, J. Siwanowicz, and L. Jaworska. The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats. Neuropharmacology 32:1397-1400 (1993).
16. Rossby, S. P., I. Nalepa, M. Huang, C. Perrin, A. M. Burt, D. E. Schmidt, D. D. Gillespie, and F. Sulser. Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. Brain Res. 687:79-82 (1995).
17. Pepin, M.-C., F. Pothier, and N. Barden. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol. Pharmacol. 42:991-995 (1992).
18. Wodarz, N., R. Rupprecht, J. Kornhuber, B. Schmitz, K. Wild, and P. Riederer. Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder. J. Affect. Disord. 25:31-38 (1992).
19. Pepin, M.-C., M. V. Govindan, and N. Barden. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol. 41:1016-1022 (1992).
20. Guiochon-Mantel, A., K. Delabre, P. Lescop, and E. Milgrom. Intracellular traffic of steroid hormone receptors. J. Steroid Biochem. Mol. Biol. 56:3-9 (1996).
21. Sanchez, E. R., J.-L. Hu, S. Zhong, P. Shen, M. J. Greene, and P. R. Housley. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock. Mol Endocrinol. 8:408-421 (1994).
22. Burke, M. J., and S. H. Preskorn. Short-term treatment of mood disorders with standard antidepressants, in Psychopharmacology: The Fourth Generation of Progress (F. E. Bloom and D. J. Kupfer, eds.) Raven Press, New York, 1053-1065 (1995).
23. s) and adenylyl cyclase. J. Neurochem. 64:724-732 (1995).
24. Miller, A. H., R. L. Spencer, B. D. Pearce, T. L. Pisell, P. Tanapat, J. J. Leung, F. S. Dhabhar, B. S. McEwen, and C. A. Biron. Effects of viral infection on corticosterone secretion and glucocorticoid receptor binding in immune tissues. Psychoneuroendocrinology, in press.
25. Montkowski, A., N. Barden, C. Wotjak, I. Stec, J. Ganster, M. Meaney, M. Engelmann, J. M. H. M. Reul, R. Landgraf, and F. Holsboer. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 7:841-845 (1995).
26. Sackey, F. N. A, R. J. G. Haché, T. Reich, J. Kwast-Welfeld, and Y. A. Lefebvre. Determinants of subcellular distribution of the glucocorticoid receptor. Mol. Endocrinol. 10:1191-1205 (1996).
27. Denton, R. R., L. P. Eisen, M. S. Elsasser, and J. M. Harmon. Differential autoregulation of glucocorticoid receptor expression in human T- and B-cell lines. Endocrinology 133:248-256 (1993)
28. Pepin, M.-C., S. Beaulieu, and N. Barden. Differential regulation by dexamethasone of glucocorticoid receptor messenger RNA concentrations in neuronal cultures derived from fetal rat hypothalamus and cerebral cortex. Cell. Mol. Neurobiol. 10:227-235 (1990).
29. O'Malley, B. W., W. T. Schrader, S. Mani, C. Smith, N. L. Weigel, O. M. Conneely, and J. H. Clark. An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog. Horm. Res. 50:333-347 (1995).
30. Renoir, J.-M., C. Mercier-Bodard, K. Hoffmann, S. Le Bihan, Y.-M. Ning, E. R. Sanchez, R. E. Handschumacher, and E.-E. Baulieu. Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression. Proc. Natl. Acad. Sci. USA 92: 4977-4981 (1995).
31. Hill, M. R., R. D. Stith, and R. E. McCallum. Interleukin 1: a regulatory role in glucocorticoid-regulated hepatic metabolism. J. Immunol. 137:858-862 (1986).
32. Sanchez, E. R. Heat shock induces translocation of the unliganded glucocorticoid receptor. J. Biol. Chem. 267:17-20 (1992).
33. Rupprecht, R., J. M. H. M. Reul, B. van Steensel, D. Spengler, M. Soder, B. Berning, F. Holsboer, and K. Damm. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. 247:145-154 (1993).
34. Scherrer, L. C., F. C. Dalman, E. Massa, S. Meshinchi, and W. B. Pratt. Structural and functional reconstitution of the glucocorticoid receptor-hsp90 complex. J. Biol. Chem. 265:21397-21400 (1990).
35. Hu, J. L., X.-J. Guan, and E. R. Sanchez. Enhancement of glucocorticoid receptor-mediated gene expression by cellular stress: evidence for the involvement of a heat shock-initiated factor or process during recovery from stress. Cell Stress Chaperones 1:197-205 (1996).
36. Nibuya, M., E. J. Nestler, and R. S. Duman. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16:2365-2372 (1996).
37. Avissar, S., Y. Nechamkin, G. Roitman, and G. Schreiber. Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression. Am. J. Psychiatry 154:211-217 (1997).
38. Shelton, R. C., D. H. Manier, and F. Sulser. cAMP-dependent protein kinase activity in major depression. Am. J Psychiatry 153:1037-1042 (1996).
39. Rangarajan, P. N., K. Umesono, and R. M. Evans. Modulation of glucocorticoid receptor function by protein kinase A. Mol. Endocrinol. 6:1451-1457 (1992).
40. Owens, M. J., J. J. Mulchahey, S. C. Stout, and P. M. Plotsky. Molecular and neurobiological mechanisms in the treatment of psychiatric disorders, in Psychiatry (A. Tasman, J. Kay, and J. A. Lieberman, eds.). W. B. Saunders, Philadelphia, 210-257 (1997).